Zacks Investment Research
29 Jun 2026, 22:51 UTC · 1h ago
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jun 2026, 22:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Abbott currently holds a Zacks Rank of #4 (Sell). — A proprietary 'Sell' rating from a tracked research provider typically signals negative short-term sentiment or poor fundamental momentum.
-0.60Abbott is projected to report quarterly revenue of $12.53 billion on July 16, 2026, representing a 12.43% year-over-year increase. — Double-digit revenue growth indicates strong top-line expansion, which is generally viewed positively by the market.
+0.40Abbott's Forward P/E ratio of 17.18 is currently at a discount compared to its industry average of 18. — Trading at a discount to industry peers suggests the stock may be undervalued, providing a potential floor for the price.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
The projected quarterly earnings per share (EPS) for Abbott is $1.28, a slight increase of 1.59% over the prior year. — Marginal EPS growth is a neutral-to-positive signal, though it lacks the strength of the revenue growth figures.
Which stocks this story touches
The stock underperformed the S&P 500 in the most recent session and currently holds a Zacks Rank of #4 (Sell).
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
